Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > HCQ failed to demonstrate efficacy against COVID-19

<< Previous

Bullboard Posts

Next >>

Comment by Bungeon Jan 30, 2021 11:21pm

161 Views

Post# 32430315

RE:RE:HCQ failed to demonstrate efficacy against COVID-19

charlierock wrote: Absolutely true ScienceFirst. It's a no brainer for what does work. Social distancing, washing your hands and wearing a mask. According to Dr. Fauci if everyone wore a N 95 mask for a month, COVID-19 would be under control and the economy could reopen. This would also prevent any mutations of the virus from taking hold. However I think it's too little too late despite adults running the US White House. That malaria drug is only good for one thing - malaria. By the way, what ever happened to using bleach?

Do some damn reading before making those statements.

The latest international testing of hydroxychloroquine treatment of coronavirus shows countries that had early use of the drug had a 79% lower mortality rate than countries that banned the use of the safe malaria drug.

https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext

<< Previous

Bullboard Posts

Next >>

Cizzle Brands, Changing Consumer Habits in Consumables